Eli Lilly Claims Drug Prevents Coronavirus Infection in Nursing Homes
NY Times
JANUARY 21, 2021
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
NY Times
JANUARY 21, 2021
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
NY Times
JANUARY 21, 2021
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Mirror
SEPTEMBER 10, 2020
This is because they often have weaker immune systems, so they can’t fight off a viral infection easily. The post How Can Nursing Homes Protect Themselves from COVID-19? Researchers have found that the elderly are particularly susceptible to the COVID-19 virus that caused the epidemic. This new situation puts.
Integra X Files
NOVEMBER 21, 2022
Many of you may be well acquainted with nursing home payment models – but a short primer can refocus us on important facts or familiarize colleagues newer to the industry. Let’s review how nursing homes get paid – and especially how that affects how pharmacies get paid for serving their residents. Areas of efficiency?
pharmaphorum
AUGUST 3, 2020
The US drugmaker is testing the antibody – called LY-CoV555 and developed in collaboration with Canadian biotech AbCellera – in a phase 3 trial to see if it can prevent the spread of the coronavirus among residents and staff in US nursing homes.
NY Times
SEPTEMBER 16, 2021
A professor, a psychiatrist and a nurse react to a Times investigation. Also: A modern Civil War; a more confident child.
pharmaphorum
AUGUST 7, 2020
The US drugmaker is testing the antibody – called LY-CoV555 and developed in collaboration with Canadian biotech AbCellera – in a phase 3 trial to see if it can prevent the spread of the coronavirus among residents and staff in US nursing homes.
Let's personalize your content